Dose of dehydromonocrotaline to induced beagle pulmonary hypertension

CHEN Dandan,ZHOU Daxin,QIAN Juying,CHEN Fadong,GUAN Lihua,DONG Lili,GE Junbo

DOI: https://doi.org/10.19577/j.cnki.issn10074406.2011.06.001

2011-01-01

Abstract:AIM To explore the appropriate dose of dehydromonocrotaline(DHMC) in the development of beagle pulmonary hypertension models.METHODS Twenty-eight beagles were randomized to receive 3 mg·kg~(-1)(n=12),2 mg·kg~(-1)(n=8) and 1.5 mg·kg~(-1) DHMC(n=8) via a Swan-Ganz Catheter in the right ventricle.The pulmonary arterial pressure was measured by the Swan-Ganz Catheter and the cardiac output(CO) was determined by the Vigilance monitror system at baseline and at 8 weeks after drug administration.Necropsy and hematoxylin-eosin staining were undertaken for dead animals.RESULTS All beagles with 2 mg·kg~(-1) DHMC were succussfully induced pulmonary hypertension with no death.However,only 5 of 12 animals with 3 mg·kg~(-1) DHMC survived during 12 weeks follow-up,and non of animals with 1.5 mg·kg~(-1) DHMC induced pulmonary hypertension.CONCLUSION DHMC induces beagle pulmonary hypertension in a dose-dependent manner.Considering both the survival and successfulness,the dose of 2 mg·kg~(-1) DHMC should be recommended in the development of pulmonary hypertension models.